ÂÜÀòÂÒÂ×

Steve Innaimo has served as Vice President of Project Management since October 2018. Steve has more than 25 years of experience in drug development from the large pharma, biotech, and contract research organization sectors. Prior to joining Intensity, Steve spent two years at Covance as Executive Director and Head of the Global Project Management Office for Covance's Clinical Development Services. He previously spent 23 years at Bristol-Myers Squibb in roles of increasing responsibility within Discovery, Oncology Project Management, and Global clinical Operations & Strategy. Steve held pan-therapeutic responsibilities across BMS' S asset portfolio and was integrally involved in managing the drug development governance process. During his time at BMS, Steve directly managed or provided development oversight for a number of BMS' immuno-oncology value driver assets including YERVOY° and OPDIVO". He has driven multiple therapies to initial and post-marketing registrations globally. Prior to BMS, Steve began his R&D career as a molecular biologist for TargeTech Inc. Steve holds a B.S. in Molecular Biology, an M.S. in Endocrinology from the University of Connecticut, and a Project Management Certificate from Boston University.